131 related articles for article (PubMed ID: 17026967)
1. Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients.
Wickström M; Danielsson K; Rickardson L; Gullbo J; Nygren P; Isaksson A; Larsson R; Lövborg H
Biochem Pharmacol; 2007 Jan; 73(1):25-33. PubMed ID: 17026967
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.
Fridborg H; Nygren P; Dhar S; Csoka K; Kristensen J; Larsson R
J Exp Ther Oncol; 1996 Sep; 1(5):286-95. PubMed ID: 9414416
[TBL] [Abstract][Full Text] [Related]
3. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
[TBL] [Abstract][Full Text] [Related]
4. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
5. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity.
Chen D; Cui QC; Yang H; Dou QP
Cancer Res; 2006 Nov; 66(21):10425-33. PubMed ID: 17079463
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells.
Cen D; Brayton D; Shahandeh B; Meyskens FL; Farmer PJ
J Med Chem; 2004 Dec; 47(27):6914-20. PubMed ID: 15615540
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specificity and type of cell death induced by trihaloacetylazulenes in human tumor cell lines.
Sekine T; Takahashi J; Nishishiro M; Arai A; Wakabayashi H; Kurihara T; Kobayashi M; Hashimoto K; Kikuchi H; Katayama T; Kanda Y; Kunii S; Motohashi N; Sakagami H
Anticancer Res; 2007; 27(1A):133-43. PubMed ID: 17352225
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific cytotoxicity and type of cell death induced by benzocycloheptoxazines in human tumor cell lines.
Murayama H; Miyahara K; Wakabayashi H; Kurihara T; Hashimoto K; Amano O; Kikuchi H; Nakamura Y; Kanda Y; Kunii S; Motohashi N; Sakagami H
Anticancer Res; 2008; 28(2A):1069-78. PubMed ID: 18507056
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines.
Ullen A; Schwarz S; Lennartsson L; Kalkner KM; Sandstrom P; Costa F; Lennernas B; Linder S; Nilsson S
Scand J Urol Nephrol; 2009; 43(2):98-103. PubMed ID: 19101859
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate.
Kishino K; Hashimoto K; Amano O; Kochi M; Liu WK; Sakagami H
Anticancer Res; 2008; 28(5A):2577-84. PubMed ID: 19035281
[TBL] [Abstract][Full Text] [Related]
13. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
14. Identification and evaluation of potential anti-cancer drugs on human neuroendocrine tumor cell lines.
Larsson DE; Lövborg H; Rickardson L; Larsson R; Oberg K; Granberg D
Anticancer Res; 2006; 26(6B):4125-9. PubMed ID: 17201123
[TBL] [Abstract][Full Text] [Related]
15. A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents.
Mirzayans R; Andrais B; Scott A; Tessier A; Murray D
J Pharm Pharm Sci; 2007; 10(2):298s-311s. PubMed ID: 17718933
[TBL] [Abstract][Full Text] [Related]
16. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295
[TBL] [Abstract][Full Text] [Related]
17. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
18. The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor?
Cvek B; Dvorak Z
Drug Discov Today; 2008 Aug; 13(15-16):716-22. PubMed ID: 18579431
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific cytotoxicity and type of cell death induced by naphtho[2,3-b]furan-4,9-diones and related compounds in human tumor cell lines: relationship to electronic structure.
Takano A; Hashimoto K; Ogawa M; Koyanagi J; Kurihara T; Wakabayashi H; Kikuchi H; Nakamura Y; Motohashi N; Sakagami H; Yamamoto K; Tanaka A
Anticancer Res; 2009 Jan; 29(1):455-64. PubMed ID: 19331186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
